FTRE (Fortrea Holdings) Other Current Liabilities: $0 Mil (As of Mar. 2026)


FTRE Fortrea Holdings Inc FTRE
64 GF Score
Price $16.84
GF Value $18.23
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings Other Current Liabilities?

Fortrea Holdings FTRE -3.63% 64 Other Current Liabilities is $0 Mil as of Mar. 2026. GuruFocus rates FTRE with a GF Score™ of 64/100 and a GF Value™ of $18.23 (Fairly Valued). The stock has 7 warning signs investors should review.

Fortrea Holdings's other current liabilities for the quarter that ended in Mar. 2026 was $0 Mil.

Fortrea Holdings's quarterly other current liabilities increased from Sep. 2025 ($-0 Mil) to Dec. 2025 ($169 Mil) but then declined from Dec. 2025 ($169 Mil) to Mar. 2026 ($0 Mil).

Fortrea Holdings's annual other current liabilities declined from Dec. 2023 ($186 Mil) to Dec. 2024 ($130 Mil) but then increased from Dec. 2024 ($130 Mil) to Dec. 2025 ($169 Mil).

Fortrea Holdings Other Current Liabilities Related Terms

Fortrea Holdings Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Fortrea Holdings's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fortrea Holdings Other Current Liabilities Chart

Fortrea Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 246.40 150.10 185.90 129.60 168.90

Fortrea Holdings Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 -0.00 168.90 0.00
FTRE
64GF Score
Fortrea Holdings Inc FTRE
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fortrea Holdings Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0 Mil mean?
Fortrea Holdings (FTRE) has a Other Current Liabilities of $0 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Fortrea Holdings.
Is Fortrea Holdings' Other Current Liabilities too high?
Fortrea Holdings' current Other Current Liabilities is $0 Mil. Overall, Fortrea Holdings has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fortrea Holdings' Other Current Liabilities compare to SEPN and MLTX?
Fortrea Holdings' Other Current Liabilities of $0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Fortrea Holdings. Fortrea Holdings's current Other Current Liabilities is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fortrea Holdings stock overvalued right now?
Based on GuruFocus' analysis, Fortrea Holdings (FTRE) is currently considered Fairly Valued. The stock's GF Value™ is $18.23, compared to a current price of $16.84 — trading 7.7% below its estimated fair value. The current Other Current Liabilities is $0 Mil. Fortrea Holdings' overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Fortrea Holdings (FTRE), the current Other Current Liabilities is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fortrea Holdings (FTRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of $16.84 is trading 7.7% below its estimated GF Value™ of $18.23. GuruFocus considers Fortrea Holdings to be Fairly Valued.

Key valuation signals for FTRE:

  • Other Current Liabilities: $0 Mil
  • GF Value™: $18.23 vs. price of $16.84 (7.7% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the FTRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges K67:Germany
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
64GF Score

Get the complete analysis for FTRE

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.84
Price
$18.23
GF Value